242 related articles for article (PubMed ID: 16287594)
1. Conventional disease-modifying antirheumatic drugs in early arthritis.
Sokka T; Hannonen P; Möttönen T
Rheum Dis Clin North Am; 2005 Nov; 31(4):729-44. PubMed ID: 16287594
[TBL] [Abstract][Full Text] [Related]
2. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
3. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
4. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
5. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
Feely MG; O'Dell JR
Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies in early rheumatoid arthritis.
Smolen JS; Aletaha D; Machold KP
Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):163-77. PubMed ID: 15588977
[TBL] [Abstract][Full Text] [Related]
8. Drug management of early rheumatoid arthritis - 2008.
Sokka T; Mäkinen H
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
[TBL] [Abstract][Full Text] [Related]
9. Progression in early rheumatoid arthritis.
Combe B
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
[TBL] [Abstract][Full Text] [Related]
10. Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomes.
Keystone EC
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):594-601. PubMed ID: 17075598
[TBL] [Abstract][Full Text] [Related]
11. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
12. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
Yen JH
Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
[TBL] [Abstract][Full Text] [Related]
13. How to predict prognosis in early rheumatoid arthritis.
Morel J; Combe B
Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):137-46. PubMed ID: 15588975
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics in rheumatoid arthritis.
Ranganathan P
Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
[TBL] [Abstract][Full Text] [Related]
15. Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritis.
Williams HJ
Br J Rheumatol; 1995 Nov; 34 Suppl 2():96-9. PubMed ID: 8535657
[TBL] [Abstract][Full Text] [Related]
16. Early inflammatory arthritis versus rheumatoid arthritis.
Finckh A
Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
[TBL] [Abstract][Full Text] [Related]
17. Early rheumatoid arthritis -- is there a window of opportunity?
Cush JJ
J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
[TBL] [Abstract][Full Text] [Related]
18. Early rheumatoid arthritis: strategies for prevention and management.
Combe B
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?
Dougados M; Smolen JS
J Rheumatol Suppl; 2002 Nov; 66():20-6. PubMed ID: 12435165
[TBL] [Abstract][Full Text] [Related]
20. Unmet needs in rheumatoid arthritis.
Bykerk V
J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
